期刊文献+

体质量指数对Ⅰ~ ⅢA期非小细胞肺癌术后患者预后的影响

Prognostic Impact of Body Mass Index on Postoperative Outcome of Patients with Stage Ⅰ-ⅢA Non-small Cell Lung Cancer
原文传递
导出
摘要 目的探讨体质量指数(body mass index,BMI)对接受手术治疗的非小细胞肺癌(non-small cell lung cancer,NSCLC)患者术后生存预后的影响。方法回顾分析2009~2014年间作者医院收治的236例行手术切除治疗Ⅰ~ⅢA期NSCLC患者的病例资料,计算患者入院时术前BMI,并分析其对术后无病生存期(disease free survival,DFS)和总生存期(overall survival,OS)的影响。中位随访时间为36. 8个月。采用Kaplan-Meier法进行生存分析,Cox回归进行单因素和多因素分析。结果正常BMI组(18. 50≤BMI <24 kg/m^2,n=75)和超重BMI组(24≤BMI <28 kg/m^2,n=161)患者的术后5年DFS(分别为45. 60%、64. 60%,P=0. 045),OS(分别为51. 30%、68. 70%,P=0. 041)比较均存在统计学差异。Cox单因素分析显示,超重BMI组较正常BMI组患者的术后DFS(HR=0. 61,P=0. 047)和OS(HR=0. 24,P <0. 001)获益;多因素分析表明,年龄、BMI和病理N分期是NSCLC术后的独立预后风险因素。结论 BMI是Ⅰ~ⅢA期NSCLC患者的术后独立预后因素之一,高BMI与NSCLC患者的术后生存获益相关。 Objective To investigate the prognostic impact of body mass index(BMI)on postoperative outcome of nonsmall cell lung cancer(NSCLC)patients.Methods A total of 236 patients with stageⅠ-ⅢA NSCLC after surgical resection in author’s hospital between 2009 and 2014 were retrospectively analyzed.The BMI before admission was calculated,and the influences of BMI on the disease free survival(DFS)and overall survival(OS)were evaluated.The median follow-up time was 36.80 months.Kaplan-Meier analysis was used to evaluate the survival rate,and Cox regression was used for the univariate and multivariate analysis.Results There were significantly different in 5-year DFS rates(45.60%vs.64.60%,P=0.045)and OS rates(51.30%vs.68.70%,P=0.041)between normal BMI group(18.50<BMI≤24 kg/m^2,n=75)and overweight BMI group(24<BMI≤28 kg/m^2,n=161).Cox univariate analysis indicated that the survival of normal BMI group was better than that of overweight BMI group(DFS:HR=0.61,P=0.047;OS:HR=0.24,P<0.001).The multivariate analysis showed that age,BMI and pathological N stage were the independent prognosis factors for NSCLC patients.Conclusion BMI is one of the independent prognostic factor of stageⅠ-ⅢA NSCLC patients,and higher BMI is closely associated with better prognosis of NSCLC patients.
作者 刘宏平 李涛 刘晓 LIU Hongping;LI Tao;LIU Xiao(Department of Pulmonary Medicine,Central Hospital of Jiaozuo Coal Industry(Group)Co.,Ltd,Jiaozuo Henan 454000,China)
出处 《华南国防医学杂志》 CAS 2018年第12期838-841,850,共5页 Military Medical Journal of South China
关键词 体质量指数 非小细胞肺癌 无病生存期 总生存期 COX回归 Body mass index Non-small cell lung cancer: Disease free survival Overall survival Cox regression model
  • 相关文献

参考文献3

二级参考文献22

  • 1陈纪春,吴锡桂,段秀芳,于学海,郑润平,王建华,李建新,顾东风.吸烟和体质指数与肺癌发病的前瞻性研究[J].中国慢性病预防与控制,2006,14(5):311-313. 被引量:15
  • 2GeofreyC.Kabat.美国吸烟者与非吸烟者肺癌流行病学概况[J].肿瘤,1996,16(4):457-466. 被引量:12
  • 3杜应秀,查清,陈小薇,陈永忠,黄兰芳,邬葭芬,冯祯智,JosephM.Wu.广州肺癌危险因素的流行病学研究[J].肿瘤,1996,16(4):492-497. 被引量:7
  • 4高玉堂.非吸烟者生活方式中的肺癌危险因素[J].肿瘤,1996,16(4):498-501. 被引量:15
  • 5中华人民共和国卫生部疾病控制司.中国成人超重和肥胖症预防控制指南[M],北京:人民卫生出版社,2006,1-20.
  • 6Ferlay J, Soerjomataram I, Ervik M, et al. Globocan 2012 vl.0, cancer incidence and mortality worldwide: Iarc cancerbase no. 11 [EB/OL].[2014-02-11].http://globocan.iarc. ft.
  • 7Berlin JA, Longnecker MP, Greenland S. Meta-analysis of epidemiologic dose-response data[J]. Epidemiology, 1993,4 (3):218-228.
  • 8Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis[J]. Stat Med, 2002,21(11):1539-1558.
  • 9Greenland S, Longnecker MP. Methods for trend estimation from summarized dose-response data, with applications to meta-analysis[J]. Am J Epidemiol, 1992,135(11):1301-1309.
  • 10Nicola O, Rino B, Sander G. Generalized least squares for trend estimation of summarized dose-response data[J]. Stata Journal, 2006,6(1):40-57.

共引文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部